<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0158">Lucy Dorrell also presented data of the initial studies working towards the development of ImmTAV molecules with HBV antigen-specificity. These have identified a potent and specific molecule for an HBV-specific ImmTAV cell with 
 <italic>in vitro</italic> results showing elimination of targets expressing HBV antigens.
</p>
